EMA: CHMP guideline on detection and management of duplicate individual cases and individual case safety reports (ICSRs)
05.07.2012
Duplicate cases can pose significant problems for analysing signals arising from pharmacovigilance databases, both artificially inflating and masking signals of disproportionate reporting.
SciencePharma
